What is Beam Therapeutics's net change in cash?

Beam Therapeutics (BEAM) reported net change in cash of -$6.64M in Q1 2026.

How has Beam Therapeutics's net change in cash changed year-over-year?

Beam Therapeutics's net change in cash decreased by 102.7% year-over-year, from $244.41M to -$6.64M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Beam Therapeutics BEAM Net Change in Cash

Net Change in Cash at other companies

Vertex PharmaceuticalsVRTX

$417.1M+268%

Arrowhead ResearchARWR

-$14.12M-111%

CRISPR TherapeuticsCRSP

$72.24M+215%

Cogent Biosciences, Inc.COGT

-$70.8M-354%

PTC TherapeuticsPTCT

-$147.9M-121%

BridgeBio PharmaBBIO

$309.88M+321%

Other financials

Income statement

See full

Revenue$31.7M+325%

Operating income-$107.2M+10.1%

Net income-$94.3M+12.9%

EPS (diluted)-$0.91+26.0%

Balance sheet

See full

Cash & equivalents$288.3M-45.4%

Total debt$250.8M+58.6%

Total equity$1.2B+3.1%

Total assets$1.5B+0.9%

Cash flow

See full

Operating cash flow-$128.5M-23.7%

CapEx$2.2M-27.2%

Free cash flow-$130.7M-22.2%

Valuation

See full

Market cap$3.51B+24.5%

Enterprise value$3.47B+51.2%

P/S21.4×-23.0×

Profitability

See full

Operating margin-226.6%-90.5pp

Net margin-742.7%—

FCF margin-234%-86.6pp

Returns & leverage

See full

Return on equity-47.1%—

Debt / equity0.2×+0.1×

Current ratio17×+8.2×

Where this comes from

Reported directly by Beam Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beam Therapeutics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beam Therapeutics's net change in cash?: Beam Therapeutics (BEAM) reported net change in cash of -$6.64M in Q1 2026.
How has Beam Therapeutics's net change in cash changed year-over-year?: Beam Therapeutics's net change in cash decreased by 102.7% year-over-year, from $244.41M to -$6.64M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.